Fatcow Icon
March of Dimes launches 2013 campaign
by Billy Cannada
Staff Writer

PICKENS COUNTY—The effort to save babies is back on in 2013.

March of Dimes recently launched its 2013 campaign with a kick-off event at FATZ Café in Easley on Tuesday. Erin Reid, March of Dimes coordinator in Pickens County, was met with a check for $25,000 to get the fundraising started..

“Since 1970, people all across the country have been walking for babies,” Reid said. “In 2012, Pickens County raised more than $105,000 during the March for Babies campaign. When we come together we take steps toward a healthier future for our babies and our community.”

Best Chevrolet of the Upstate and Best Kia of the Upstate got the fundraising going with quite a large donation. In addition to the $25,000 gift, the two dealerships announced they will face off against each other in the “Fill the Front campaign,” which will collect donations for the cause.

“A little friendly competition really inspires people to do their best, and March of Dimes and the kids it helps deserve no less from us,” said Pete Mirante, owner of Best Upstate. “At Best Chevorlet of the Upstate and Best Kia of the Upstate, we are proud to stand behind this cause and help it do its work. I’m sure everybody out there joins me in wanting to see March of Dimes continue making sure babies get the best start possible.”

Baptist Easley CEO and 2013 March for Babies Chairman Roddey Gettys said there is a great cause behind all of this.

“The March of Dimes is inspired by all babies,” Gettys said. “They are the millions of reasons behind our urgent mission and why everyday March of Dimes is fighting for the babies in our lives. The healthy grandchildren, the neighbor born too soon or too small or the friend whose child didn’t survive. We raise money so that one day every parent can experience the joy of a healthy baby.”

March of Dimes, celebrating its 75th anniversary this year, seeks cures for a wide array of birth defects and diseases, and it sponsors programs that help parents beore and after the birth of their child.

“While we are proud to announce that we have seen a decrease in premature birth, birth defects and infant mortality, we still have a lot of work to do,” Gettys said. “Each minute, another child is born too soon in our country.”

Last year, Shaw Industries was the team that raised the most money for March of Dimes, bringing in $11,600. Gettys said a lofty goal has been set for this year’s fundraising.

“The March of Dimes Pickens County goal for March for Babies 2013 is $118,000,” Gettys said. “That’s $118,000 to offer hope and solutions for all babies.”

The fundraising concludes with a walk to celebrate in April. This year, the walk will be held at Old Market Square in Easley.

“One day, all babies will be born healthy, but we have to walk to get there,” Gettys said. “Let’s get out there on April 27th, the day of March for Babies, and walk.”

To learn more about March of Dimes, visit www.marchofdimes.com/southcarolina.

Share This Article |
similar stories

Easley football makes spring debut | 29 days ago by Billy Cannada
Staff Writer

Bob Brown | 22 days ago

Doug Turner | 8 days ago

Luther Cleo Gantt | 14 days ago

Mildred (Millie) Bratka Riley | 8 days ago

Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Photo contest deadline is Friday
COLUMBIA — The deadline is Feb. 15 for the S.C. Department of Commerce’s ninth annual Rural Summi...
Feb 12, 2013 | 0 0 comments | 55 55 recommendations | email to a friend
full story
Newberry Opera House to host John Michael Montgomery
NEWBERRY — John Michael Montgomery, a Kentucky-born artist whose personal contributions to the st...
Feb 05, 2013 | 0 0 comments | 55 55 recommendations | email to a friend
full story

News
ID02_18218308_web.jpg
slideshow
E470_17642865_web.jpg
slideshow
FHHB_18227527_web.jpg
slideshow
CUO9_1630484_web.jpg
slideshow
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 16 views | 0 0 comments | 7 7 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Read More News
Sports
ID02_18218308_web.jpg
slideshow
E470_17642865_web.jpg
slideshow
FHHB_18227527_web.jpg
slideshow
CUO9_1630484_web.jpg
slideshow
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 16 views | 0 0 comments | 7 7 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Read More Sports
Opinion
ID02_18218308_web.jpg
slideshow
E470_17642865_web.jpg
slideshow
FHHB_18227527_web.jpg
slideshow
CUO9_1630484_web.jpg
slideshow
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 16 views | 0 0 comments | 7 7 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Read More Opinion
Latest Video
Weather
Sponsored By:

RSS Feeds
All articles feed
News feed
Sports feed
Videos feed
Obituaries feed
Opinion feed
Local Features
ID02_18218308_web.jpg
slideshow
E470_17642865_web.jpg
slideshow
FHHB_18227527_web.jpg
slideshow
CUO9_1630484_web.jpg
slideshow
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 16 views | 0 0 comments | 7 7 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
Read More Local Features
Poll
Sponsored By:

ID02_18218308_web.jpg
slideshow
E470_17642865_web.jpg
slideshow
FHHB_18227527_web.jpg
slideshow
CUO9_1630484_web.jpg
slideshow
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 16 views | 0 0 comments | 7 7 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
View Previous Polls
Special Sections
ID02_18218308_web.jpg
slideshow
E470_17642865_web.jpg
slideshow
FHHB_18227527_web.jpg
slideshow
CUO9_1630484_web.jpg
slideshow
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 16 views | 0 0 comments | 7 7 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet
ID02_18218308_web.jpg
slideshow
E470_17642865_web.jpg
slideshow
FHHB_18227527_web.jpg
slideshow
CUO9_1630484_web.jpg
slideshow
More Americans choosing generic drugs
by Brandpoint (ARA) Sponsored Content
Jun 19, 2013 | 16 views | 0 0 comments | 7 7 recommendations | email to a friend | print
(BPT) - Have you ever gone to fill a prescription and the pharmacist asks if you’d like the generic version of the medication, perhaps reminding you that it is at a considerable cost savings over the brand-named drug? Or you’re told that your insurance will only cover the generic equivalent of what your doctor has prescribed?
The first time this happens, you undoubtedly have many questions: Is there a difference between branded and generic medicines? Will the generic be just as safe and effective? Do insurance companies prefer generics? If you have, you’re not alone in asking these questions.
 It’s no secret that the rising costs of health care services and medications have been affecting millions of Americans – indeed, our economy – and will undoubtedly continue to do so in the future. However, generic alternatives have proven to be a critical factor in slowing down national health care spending. In fact, generic drug use has saved America’s health care system approximately $1.07 trillion over the past decade, with $192.8 billion in savings achieved in 2011 alone, according to a 2012 study by the IMS Institute for Healthcare Informatics.
However, while consumers recognize the cost advantage of generic drugs, they are reminded, from time to time, of the question of quality and efficacy of generic medications versus name-brand equivalents. Consumers should know that the U.S. Food and Drug Administration, the federal agency responsible for protecting and promoting public health, requires that generic drugs must be identical or “bioequivalent” to brand name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
“The U.S. FDA tests generic medicines just as rigorously as their branded counterparts,” explains Venkat Krishnan, senior vice president and regional director at Ranbaxy Inc. “Generic drugs must meet rigid qualifying criteria before they can be made available to the general public. At Ranbaxy, we have stringent protocols in place to ensure that our products are both safe and effective, and we stand behind that, focused on our philosophy of ‘Quality and Patients First.’”
People are choosing generics in increasing numbers, out of economic necessity and because they are increasingly better informed.Of the 4 billion prescriptions written in 2011, nearly 80 percent were dispensed using generic versions of their brand name counterpart. With generics, consumers have the option of paying a price that is as much as 85 percent lower than name-brand drugs.
If you have questions about switching to a generic prescription, have a conversation with your doctor or pharmacist, or visit www.gphaonline.org for more information and the facts about generic drugs.
Share This Free article |
Comments
(0)
Comments-icon Post a Comment
No Comments Yet